Cetirizine dihydrochloride

ADVERTISEMENT

Identification

Molecular formula
C21H27Cl2N3O3
CAS Number
83881-52-1
IUPAC Name
2-[4-[(4-tert-butylphenyl)methyl]piperazin-1-yl]-1-[3,4,5-tris(hydroxymethyl)phenyl]ethanone;dihydrochloride
Molecular Weight
461.82g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
0.8705g/cm3
Synonyms
Acetophenone, 2-(4-(p-tert-butylbenzyl)piperazinyl)-3', 4', 5'-trimethoxy-, dihydrochloride
Interesting facts

Interesting Facts about 2-[4-[(4-tert-butylphenyl)methyl]piperazin-1-yl]-1-[3,4,5-tris(hydroxymethyl)phenyl]ethanone;dihydrochloride

This compound is an innovative and complex chemical structure, showcasing the rich architecture of organic chemistry. It belongs to a class of molecules that exhibit significant biological activity and can pave the way for exciting research in medicinal chemistry.

Key Features:

  • Diverse Functional Groups: The presence of piperazine, hydroxymethyl, and ketone groups in its structure allows for versatile interactions within biological systems.
  • Potential Therapeutic Applications: Compounds with similar structures have been studied for their roles as medication candidates, particularly in the fields of neuropharmacology and oncology.
  • Synthetic Challenge: The synthesis of this compound can be quite intricate, often requiring multi-step procedures that highlight the creativity and skill involved in organic synthesis.

As researchers explore the interactions of this compound with biological targets, its unique characteristics may uncover new therapeutic pathways. The varied substituents offer opportunities for modification, which can lead to a wide range of derivatives with potentially enhanced properties.


To quote a well-known chemist: "The beauty of chemistry lies in the complexity of its compounds and the simplicity of the ideas we can derive from them." This sentiment perfectly encapsulates the significance of compounds like this one in expanding our understanding of medicinal chemistry and physiological interactions.

ADVERTISEMENT